Biotechnology News

January 7, 2013

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”) (OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that chairman and CEO Gary Rabin will present at Biotech Showcase 2013 on Tuesday, Jan. 8,...

January 7, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tobira's announces positive topline data from its Phase 2b trial of cenicriviroc for the treatment of HIV.

January 7, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences (Nasdaq:GILD) today announced several updates regarding its late-stage pipeline candidates for the treatment of chronic hepatitis C virus (HCV) infection. The company released new results from...

January 7, 2013

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc.(ADMA), a late-stage biotechnology company focused on developing specialty immune globulin therapeutics and the commercialization of human plasma, announced it has entered into a $6 million...

January 7, 2013

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the J.P. Morgan 31st Annual Healthcare Conference in San Francisco, California on Tuesday, January 8th, at 10:...

January 7, 2013

SUDBURY, Mass.--(BUSINESS WIRE)--In an industry first, Arradiance, Inc. announced today, the demonstration of cryogenic Microchannel Plate (MCP) devices operating at MOhm resistances, enabling MHz data acquisition rates.

January 7, 2013

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis will present at OneMedForum

January 7, 2013

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--The National Foundation for Cancer Research (NFCR) has listed the SQUID-based cancer imaging technology developed by MHTX’s (OTCBB: MHTX) Senior Scientific subsidiary as a “2012 Research Breakthrough.”...

January 7, 2013

LEXINGTON, Ky.--(BUSINESS WIRE)--MedPro Safety Products, Inc. (OTCQB:MPSP), a leading developer of transformational technologies that enable safer medication delivery through both injection and IV delivery, today announced it has signed an Asset...

January 7, 2013

WOBURN, Mass.--(BUSINESS WIRE)--Aphios, developer of CFI pathogen inactivation technology, offers virology testing services to facilitate and support scaled down viral clearance and inactivation validation studies.

January 7, 2013

PRINCETON, N.J.--(BUSINESS WIRE)--Celator® Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs

January 7, 2013

BOSTON--(BUSINESS WIRE)--Today, GenomeQuest™ and Cambridge Healthtech Associates™ reported on their healthcare industry calibration study on genomic interpretation (I-Study: Genomic Interpretation™ – Who will pay, what is needed and how to...

January 7, 2013

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., announced today that David Pernock, the Company’s Chairman and CEO, will be presenting at the 6th Annual OneMedForum San Francisco 2013 on Wednesday, January 9, 2013.

January 7, 2013

DEERFIELD, Ill. & PALO ALTO, Calif.--(BUSINESS WIRE)--Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) and Affymax, Inc. (Nasdaq: AFFY) today announced that Takeda Pharmaceuticals America, Inc. (TPA) has entered into a supply agreement for...

January 7, 2013

BRISBANE, Australia--(BUSINESS WIRE)--Clinical Network Services (CNS), an Australian based CRO offering integrated development services in the planning, implementation and delivery of Phase 1 and 2 trials, today announced that it has acquired the...

January 7, 2013

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn will be traveling to San Francisco to present an update on the company’s technology during the 31st Annual J.P. Morgan Healthcare Conference on January 9, 2013 at 3:15 PM PT.

January 7, 2013

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a definitive Asset Contribution Agreement with Geron...

January 7, 2013

CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a medical device company, announced the completion of their implantable generator for use in chronic pain applications. The device, named Altius™, delivers their patented high frequency Electrical...

January 7, 2013

CAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Newcastle University, U.K., on behalf of the U.K. National Cancer Research Institute (NCRI) CML Working Group, today announced an agreement to...

January 7, 2013

JERUSALEM--(BUSINESS WIRE)--BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that the results of the interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available...

January 7, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced unaudited fourth quarter and full-year 2012 revenues and provided business updates, including the expected timing of data readouts for two ongoing...

January 7, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

January 7, 2013

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals announced positive, statistically significant data from the Company’s Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb® (also referred to as SPI-014).

January 7, 2013

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions announces preliminary 2012 financial results and provides guidance for 2013

January 7, 2013

DANVERS, Mass.--(BUSINESS WIRE)--Cell Signaling Technology announces the issuance of US Patent No. 8,288,102, relating to PCR-based methods for detection of EML4-ALK (anaplastic lymphoma kinase) polynucleotides in patient samples.

January 7, 2013

BURLINGAME, Calif.--(BUSINESS WIRE)--Reset Therapeutics, the leader in harnessing the power of the body’s internal clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications, today announced that...

January 7, 2013

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien’s Tri-Staple technology platform for endoscopic surgical stapling has achieved more than $1 Billion in product sales since launching in mid-2010.

January 7, 2013

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) today announced that it has appointed Joshua Young as Vice President of Investor Relations. Young will succeed Stacey Desrochers who will continue as a key member of Bruker’s...

January 7, 2013

CAMBRIDGE, UK--(BUSINESS WIRE)--Almac and TTP Labtech announced today the formation of an alliance in the field of fluorescence lifetime (FLT) technology to provide class leading screening performance. This will give customers of either party...

January 7, 2013

BOULDER, Colo.--(BUSINESS WIRE)--Clovis announces 2013 Objectives and Financial Guidance

January 7, 2013

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg unaudited net sales for the fourth quarter of 2012 were $73 million and unaudited AMPYRA 2012...

January 7, 2013

FREMONT, Calif.--(BUSINESS WIRE)--Nitinol Devices & Components (NDC) today announced the appointment of Doug Hutchison as its Chief Commercial Officer effective December 31, 2012 to oversee all of NDC’s commercial activities relating to the...

January 7, 2013

CARLSBAD, Calif.--(BUSINESS WIRE)--GenASIs Go-Path positions ASI as a leader in computer aided pathology immunohistochemistry analysis for cancer and other IHC applications.

January 7, 2013

LINKÖPING, Sweden--(BUSINESS WIRE)--Regulatory News: SECTRA (STO:SECTB): Seven Hudson Valley locations of Orthopedic Associates of Dutchess County (OADC) are now using PACS from the medical imaging IT company Sectra (...

January 7, 2013

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (“EPIRUS”), formerly known as fourteen22 Inc, announced that its lead asset, BOW-015, achieved bioequivalence to Remicade® in a single dose comparator trial. In February 2012, the United...

January 7, 2013

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal...

January 6, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today its key “Alnylam 5x15™” pipeline and partner program goals for 2013 through 2014. “In 2012, we made tremendous...

January 6, 2013

SAN FRANCISCO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today outlined the company’s strategy and defined key 2013 business priorities to support continued growth and the creation of long-term shareholder value. Vertex’...

January 6, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced a business update, including preliminary fourth quarter 2012 financial results and its outlook for 2013. The company will present further details at the...

January 5, 2013

DENVER--(BUSINESS WIRE)--DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will participate in the 31st Annual J.P. Morgan Healthcare Conference being held January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco, CA...

January 4, 2013

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTCQB: SNTI) announced today that it has entered into a securities purchase agreement to raise approximately $3.0 million in gross proceeds through the...

January 4, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 31st Annual JPMorgan Healthcare Conference in San Francisco. John C. Martin, PhD, Gilead’s...

January 4, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) reported today that equity awards were made to two new employees subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employees were granted stock...

January 4, 2013

GREAT NECK, N.Y.--(BUSINESS WIRE)--Brain & Behavior Research Foundation (formerly NARSAD/Nat. Alliance for Research on Schizophrenia & Depression) for mental health research names psychiatrist Jeffrey Borenstein, M.D., Acting President

January 4, 2013

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2012 on January 24

January 4, 2013

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, announces that Mr. Douglas Doerfler, President & CEO of MaxCyte, will present a business and technical update during...